Application Note
Profiling compound effect on immune cells by combining ImmuSignature assays and LEGENDplex bead-based multiplex protein quantification
A crucial step in drug discovery is assessing a therapeutic candidate´s capability to interact with the immune system. During this process, in-vitro immune cell screening can be used to uncover novel drug targets, reveal disease mechanisms, prioritize targets, support mechanism of action studies, help unearth biomarkers, and explore the realm of immunotherapy.
Read this application note to learn how ImmuSignature™ assays and BioLegend LEGENDPlex™ quantification can streamline your workflow, and provide rapid, robust, and sensitive results on compounds’ immunogenicity in a miniaturized semi-automated format.
For research use only. Not for use in diagnostic procedures.
Download Resource
Profiling compound effect on immune cells by combining ImmuSignature assays and LEGENDplex bead-based multiplex protein quantification